Lee Sang-hoon (; born January 1963) is a South Korean biologist and business executive. He is the founder and CEO of .
In November 2025, Forbes estimated his net worth at US$1.5 billion.
Early life and education From 1982 to 1989, Lee studied biology at Seoul National University, where he earned a Bachelor of Science, followed by a Master’s degree in developmental biology. In 1994, he completed a Ph.D. in Molecular, Cellular and Developmental Biology at the Ohio State University. Lee completed postdoctoral fellowships at Harvard Medical School, University of California, San Francisco, and Stanford Medical School.
Career He led research at several companies, including AstraZeneca, Genentech, and Exelixis.
In 2008, Lee co-founded PharmAbcine. He then served as head of the biotech division at Hanwha Solutions.
In 2016, Lee founded ABL Bio. The company listed on the KOSDAQ in 2018.
He became a billionaire in 2025 after ABL Bio signed a licensing and research deal with Eli Lilly.
References